| Net Cash Provided by (Used in) Operating Activities |
$198,942,000 |
USD |
-5.5% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$166,671,000 |
USD |
-13% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$32,271,000 |
USD |
13% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
2,000,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
476,712,000 |
shares |
-0.95% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$26,022,000 |
USD |
|
Q1 2024 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$0 |
USD |
|
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$65,272,000 |
USD |
55% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$237,000 |
USD |
-91% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$121,450,000 |
USD |
0.59% |
Q4 2024 |
FY 2024 |
| Depreciation |
$133,372,000 |
USD |
-6.1% |
Q3 2025 |
Q3 2025 |
| Property, Plant and Equipment, Gross |
$4,678,882,000 |
USD |
3.3% |
Q3 2025 |
Q3 2025 |
| Deferred Income Tax Expense (Benefit) |
$34,416,000 |
USD |
-5.7% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$117,854,000 |
USD |
2.2% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$1,972,218,000 |
USD |
-2.6% |
Q3 2025 |
Q3 2025 |
| Amortization of Intangible Assets |
$70,672,000 |
USD |
0% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$121,213,000 |
USD |
2.6% |
Q4 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
$46,296,000 |
USD |
12% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |